





| 货号 | HB613086 |
|---|---|
| 品牌 | abinScience |
| 描述 |
Pavunalimab (HB613086) is a research-grade recombinant antibody targeting CD223. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| 种属反应性 | Human |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 同种型 | half-IGG1-kappa/(scFv-heavy-kappa)-h-CH2-CH3 |
| 表达系统 | Mammalian cells |
| 靶标 | FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3, CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4 |
| 内毒素水平 | < 10 EU/mg |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| Accession号 | P18627 & P16410 |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 别名 | Bispecific, XmAb-22841, Bavunalimab, 2329669-78-3 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype Control | Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507) |







24小时产品查询

扫一扫关注我们

专属渠道经理